Search
for
Sort by
Research 391–420 of 1000+
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Impact of Chemotherapeutic Drug on People living with Cancer
- Hair Changes due to Drugs
- Hair Loss Effects and Surgical/Drug Treatments for the Alopecias
- Original article / Article original Counterfeit drugs and pharmaceutical preparations seized from the black market among bodybuilders Médicaments de contrefaçon et préparations pharmaceutiques saisis sur le marché noir parmi les bodybuilders
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- The PDGF/PDGFR pathway as a drug target
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- PROTECTIVE EFFECT OF TRIBULUS TERRESTRIS ON HEPATO-BIOCHEMICAL PARAMETERS OF ALBINO RAT AFTER TREATMENT WITH DRUG CYPROTERONE ACETATE
- Microgel emulsion loaded with recombinant oil body as a new drug delivery carrier to promote wound repair
- DEVELOPMENT OF CHEMICAL FINGERPRINTS TO DIFFERENTIATE THE CONTROVERSIAL INDIAN HERBAL DRUGS ECLIPTA PROSTRATA AND WEDELIA CALENDULACEA (BHRINGRAJA)
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS
- Stress, Hair Growth Control, and the Neuro-Endocrine-Immune Connection
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Screening Potential Drugs From Nitric Oxide Donors for Treating Alopecia Based on Network Pharmacology and Experimental Validation